Skip over main navigation
  • Log in
  • Basket: (0 items)
Haemochromatosis UK
☏ Help LineTest Kit MembershipDonate 
  • Twitter
Menu
  • Get help
    • Newly Disagnosed Essentials
    • Be a Member
    • Our Advice Services
    • Our Genetic Testing
    • Our Vita Vibes
  • Info
    • What is GH
    • All our guides
    • Videos
    • Type 1 GH
    • All Types of GH
    • Treatment & care
    • Talking about GH
    • Blood Donation in the UK
    • Private venesections
    • FAQs
  • Get involved
    • Be a Member
      • Be a Member
      • Members Only
    • Be a Friend
    • Be a Champion
    • Give money
      • Donate to HUK
      • Our appeals
      • A gift in your will
      • Online shopping partners
      • Pay In money you've raised
    • Give time, volunteer
      • Change the world
      • Current opportunities
    • Fundraise for us
      • Fundraising for us
      • Fundraising Events
      • Set up a fundraising page
      • Pay in money you've raised
    • Campaign with us
  • For health workers
    • Intro for Clinicians
    • Clinical guidelines
    • Clinician events
    • Primary care
      • Diagnosis & care
      • GP training
      • Pharmacy
    • Secondary care
      • Nursing
      • Arthropathy
      • Venesection Best Practice
    • Medical research grants
    • Clinic Packs
  • News/Events
    • News
    • All Events
    • Iron Brews / Socials
    • Fundraising Events
    • Our blog
  • Shop
  • About us
    • Our charity
      • Our trustees
      • Our team
      • Our clinical advisors
      • All Party Parliamentary Group
    • Our projects
      • Pass it On England
      • Research
      • Venesection best practice
    • Careers
    • Contact us
  • Admin
    • Log in
  • Basket: (0 items)
  • Treatment & Care

Treatment & Care

Genetic haemochromatosis is an inheritable condition; it can be shared by family members. In the UK, as many as 1 in 150 people (England & Wales) or 1 in 113 people (Scotland) or 1 in ~10 (Northern Ireland) have the condition, but most are unaware that they do. The condition is particularly prevalent in people of northern European ancestry.

People with genetic haemochromatosis find it difficult to process iron in their bodies. Over time (usually several years or decades), the amount of iron builds up. This is known as iron overload, which can lead to chronic fatigue, painful joints and issues like diabetes, liver and heart disease. Sometimes people don’t have any symptoms at all.

With treatment, many people live full and active lives with genetic haemochromatosis.

Initial Diagnosis

The condition is diagnosed through blood tests, which can be arranged by your GP. The tests come in two stages.

Stage One – initial blood tests

The first stage is to do a simple blood test for serum ferritin, transferrin-saturation, full blood count and liver function tests. This will give an indication if you have too much iron in your body.

If your initial blood test results are outside normal range, you should then be referred for a subsequent genetic test.

The normal ranges for these test results vary for men and women.

  • Men should be referred for a genetic test if their full blood count (FBC) is normal and serum ferritin (known as SF) is over 300μg/l or transferrin saturation (known as random TSAT) is over 50%
  • Women should be referred for a genetic test if their full blood count (FBC) is normal and Serum ferritin (known as SF) is over 200μg/l or transferrin saturation (known as random TSAT) is over 40%

Stage Two – genetic test

If your GP discovers that your initial blood tests are outside the normal range, they should arrange a second, genetic test. This will check for the common gene variants of genetic haemochromatosis (known as c282y and H63d). The genetic test will show if you have genetic haemochromatosis or not.

For a genetic test you will be asked to give a small blood sample. You will receive the results of this test within 4-6 weeks.  If the test confirms that you have genetic haemochromatosis, either your GP or a genetic counsellor will contact you to explain the results.

There are three common variations of genetic haemochromatosis :

  • C282y/c282y (also known as “c282y homozygous”). This is the most common variant of the condition in the UK, affecting over 9 in every 10 people diagnosed. People with this variation tend to load iron much more quickly compared to other people with genetic haemochromatosis.

  • C282y/H63d (also known as “compound heterozygous”). This is a less common variant of the condition, affecting up to 5 in every 100 people diagnosed. People who are compound heterozygous tend to load iron less rapidly than other people with genetic haemochromatosis.

  • H63d/H63d (also known as “H63d or non-c282y homozygous”). This is a less common variant of the condition, affecting up to 5 in every 100 people diagnosed. People who are H63d homozygous tend to load iron less rapidly than other people with genetic haemochromatosis.

There may also be other genetic mutations which cause iron overload. For now we do not fully understand them and new research is needed.

Following a diagnosis of genetic haemochromatosis

If a genetic test confirms a diagnosis of genetic haemochromatosis, your doctor will organise a range of additional tests. These will vary from person to person, depending on the level of iron overload in your body.

Too much iron in the body over a long period can cause damage to many parts of the body. Excess iron can be extremely toxic.  It can affect many parts of the body. Your doctor will check your liver particularly as it is most often affected.

FerriScan

This is a specialized, non-invasive MRI-based diagnostic tool used to measure liver iron concentration (LIC). It provides a quantitative assessment of the amount of iron deposited in the liver. This scan is particularly useful for diagnosing and monitoring conditions associated with iron overload, such as haemochromatosis, thalassemia, and other transfusion-dependent iron overload. Here are some key points about FerriScan:

  1. Procedure:
    • The patient undergoes a magnetic resonance imaging (MRI) scan, during which specific sequences are used to measure the magnetic properties of iron in the liver tissue.

    • No contrast agents are required, making it safe for patients with allergies or kidney issues.

  2. Benefits:
    • Accuracy: Provides precise quantification of liver iron concentration.

    • Non-invasive: Unlike liver biopsy, FerriScan does not require tissue sampling.

    • Repeatable: Can be used regularly to monitor changes in liver iron levels over time without risk to the patient.

  3. Clinical Use:
    • Diagnosis: Helps in diagnosing conditions that cause iron overload.

    • Monitoring: Tracks the effectiveness of treatments aimed at reducing iron levels, such as phlebotomy or chelation therapy.

LiverMultiScan

This is another advanced MRI-based diagnostic tool used to assess the health of liver tissue. It provides detailed information about liver tissue characteristics, including inflammation, fibrosis, and fat content. This tool is used in the evaluation of a variety of liver conditions, including non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and chronic hepatitis. Here are some key points about LiverMultiScan:

Procedure:

  • The patient undergoes an MRI scan with specific imaging protocols designed to capture detailed images of liver tissue.

  • Different sequences are used to assess various aspects of liver health, such as T1 and T2* mapping.

Benefits:

  • Comprehensive Assessment: Provides a multifaceted evaluation of liver health, including quantification of fat, iron, inflammation, and fibrosis.

  • Non-invasive: Similar to FerriScan, it avoids the need for invasive procedures like liver biopsy.

  • Early Detection: Can identify liver disease at early stages, potentially before significant symptoms appear.

Clinical Use:

  • Diagnosis: Helps in diagnosing a wide range of liver conditions.
  • Monitoring: Assesses the progression of liver disease and the effectiveness of therapeutic interventions.

  • Prognosis: Provides information that can help predict the likely course of liver disease.

Both FerriScan and LiverMultiScan offer non-invasive, accurate, and repeatable ways to assess liver health, aiding in the diagnosis, monitoring, and management of liver conditions.

Here is a video explaining the use of FerriScan click here

We have compiled a list of UK providers of FerriScan:

Site

Address

Addenbrookes Hospital 

Addenbrookes Hospital, Hills Road, Cambridge, CB2 0QQ, United Kingdom

Alder Hey Children's NHS Foundation Trust 

E Prescot Rd, Liverpool, L14 5AB, United Kingdom

Barking, Havering and Redbridge University Hospitals 

4 Lyon Rd, Romford, RM1 2BA, United Kingdom

Barts Health 

The Royal Hospital, Whitechapel Road, London, E1 1BB, United Kingdom

Birmingham Children's Hospital 

Steelhouse Ln, Queensway, Birmingham, B4 6NH, United Kingdom

Great Ormond Street Hospital, NHS Trust 

Great Ormond St, London, WC1N 3JH, United Kingdom

Guy's and St Thomas' NHS FT 

St Thomas' Hospital, Westminster Bridge Rd., London SE1 7EH, United Kingdom

Hammersmith Hospital - Imperial College Healthcare 

72 Du Cane Rd., London, W12 0HS, United Kingdom

Homerton University Hospital 

Homerton University Hospital

Kings College Hospital MRI 

Denmark Hill, London, SE5 9RS, United Kingdom

Leeds Children's Hospital 

Leeds Children's Hospital

Leeds Teaching Hospitals NHS Trust 

St James University Hospital, Beckett St, Leeds, LS9 7TF, United Kingdom

London North West Healthcare, Central Middlesex Hospital 

Acton Ln, London, NW10 7NS, United Kingdom

Luton and Dunstable Hospital 

NHS Foundation Trust, The L&D Hospital, Lewsey Rd., Luton, LU4 0DZ, United Kingdom

Manchester Children's Hospital 

Oxford Rd, Manchester, M13 9WL, United Kingdom

Newham University Hospital 

Glen Rd, London, E13 8SL, United Kingdom

Nottingham University Hospitals 

Derby Rd, Lenton, Nottingham, NG7 2UH, United Kingdom

One Welbeck Imaging and Diagnostics 

1 Welbeck St, London, W1G 0AR, United Kingdom

Oxford University Hospital NHS FT 

Radiology, Churchill Hospital Old Rd, Headington, Oxford, UK OX37LE

Royal Belfast Hospital  

274 Grosvenor Rd., Belfast, BT12 6BA, United Kingdom

Royal Hospital for Children 

1345 Govan Rd., Glasgow, G51 4TF, United Kingdom

Sandwell and West Birmingham Hospitals NHS Trust 

Treatment Centre, City Hospital, Dudley Road, Birmingham, B18 7QH, United Kingdom

Sheffield Children's NHS Foundation Trust 

Clarkson St. Broomhall, Sheffield S10 2TH, United Kingdom

Sheffield Teaching Hospitals NHS Foundation Trust 

Royal Hallamshire Hospital, Broomhill, Glossop Rd, Sheffield S10 2JF, United Kingdom

South Tyneside and Sunderland NHS Foundation Trust 

Harton Ln, South Shields NE34 0PL, United Kingdom

St Mary's Hospital Imperial College Healthcare 

St Mary's Hospital, Prade St, London W2 1NY, United Kingdom

Sunderland Royal Hospital 

Kayll Rd, Sunderland SR4 7TP, United Kingdom

The Harley Street Clinic 

Harley street clinic, 35 Weymouth Street The, London W1G 8BJ, United Kingdom

University College London (UCL) 

The Roger Williams Building, 69-75 Chenies Mews, London WC1E 6HX, United Kingdom

University Hospital Southampton 

Tremona Rd, Southampton SO16 6YD, United Kingdom

University Hospitals of Derby and Burton NHS Foundation Trust 

Uttoxeter Rd, Derby DE22 3NE, United Kingdom

University Hospitals of Leicester NHS Trust 

Groby Rd, Leicester LE3 9QP, United Kingdom

Velindre NHS Trust 

Unit 2 Charnwood Court Heol Billingsley, Parc, Nantgarw, Cardiff CF15 7QZ, United Kingdom

Whittington Hospital 

Magdala Ave, London N19 5NF, United Kingdom

As well as a list of UK providers of Liver Multi Scan test: 

Site

Address

Nottingham City Hospital

Hucknall Road, Nottingham, NG5 1PB, United Kingdom

Southampton General Hospital

Tremona Rd, Southampton, SO16 6YD

Basingstoke and North Hampshire Hospital

Aldermaston Rd, Basingstoke, Hampshire, RG24 9NA, United Kingdom

Preventicum

38 Cursitor St, Chancery Ln, London, WC2A 1EN, United Kingdom

Lumen Harley Street

17 Harley Street, London, W1G 9QH, United Kingdom

Mayo Clinic Healthcare

15 Portland Place, Marylebone, London, W1B 1PT, United Kingdom

Nottingham City Hospital

Hucknall Road, Nottingham, NG5 1PB, United Kingdom



    

Fibroscan tests

You should be offered a Fibroscan test, which is a type of ultrasound. It assesses the wobbliness (or elasticity) of the liver. The test takes only a few minutes and causes little or no discomfort. Sometimes, this will be followed by a liver biopsy to assess the severity of liver scarring (also known as cirrhosis).

People with serum ferritin of over 1000 μg/l should be referred to a hepatologist, to check for excess liver scarring or damage caused by high iron levels.

If cirrhosis is detected, you will be referred to a hepatologist to check the liver with ultrasound every 6 months along with a blood test (known as AFP) which can identify any early liver cancer, which is potentially curable if caught early.

You may also be offered – based on your particular circumstances – the following tests :

DEXA tests

Your doctor may request a DEXA scan, which is a type of high-resolution X-ray. This is used to check for osteoporosis and bone wear, which can occur as a result of iron overload. A DEXA scan is totally painless and takes only a few minutes.

Cardiology/ECG tests

Your doctor may request cardiology screening, which may include ECG and cardio ultrasound tests. These tests are painless and take only a few minutes.

Joint tests

Your doctor may refer you for specialist rheumatology assessment, particularly if you are experiencing acute joint pain or have arthropathy (joint inflammation).

Endocrine tests

Your doctor may refer you to an endocrinologist, particularly if your blood tests show early signs of diabetes or Addison’s Disease.

Initial Treatment

For most people, treatment for genetic haemochromatosis is simple and effective; it’s a form of regular blood donation known as “venesection”.

Initially, your doctor will ask you to attend hospital or a clinic weekly or fortnightly to have up to 1 unit (450 ml) of blood drawn. This has the effect of stimulating the body into producing more blood, which draws excess iron out of the organs and soft tissues. Then – a week or two later - another unit of blood is drawn, and the process repeats.

You’ll need to have a venesection regularly until your serum ferritin (SF) is between 20-30 μg/l and your transferrin saturation (TSAT) is below 50%. Depending upon your iron levels at initial diagnosis, it may take several months to several years of venesection to reduce your iron levels to normal.

Venesection isn't always an option for people (for example, if venous access is consistently troublesome); for a small number, alternative therapies including chelation therapy may be used instead (or interchangeably). These approaches use drugs administered orally or by injection which bind to excess iron to enable it to be passed out of the body.  Different drugs are available, these include Deferoxamine, Deferasirox and Deferiprone.

Ongoing (or "maintenance") Treatment

Following a period of regular venesection, you will reach “maintenance” once your serum ferritin (SF) is below 100 μg/l and transferrin saturation (TSAT) is below 50%.

You will need to continue to have venesection periodically to maintain your iron levels at normal levels, ideally where serum ferritin (SF) is below 50 μg/l and transferrin saturation (TSAT) is below 50%. The frequency of venesection varies from person to person and can range from every few weeks to every few months.

Once in maintenance, many people can go on to be regular blood donors, helping others. The NHS Blood & Transplant service accept donors with genetic haemochromatosis for venesection/donation from 6 weekly intervals upwards.

You should also be offered a periodic appointment with your consultant (either 6 monthly or 12 monthly) to discuss your treatment and to arrange a liver ultrasound and/or Fibroscan.

Family screening

Genetic haemochromatosis is inherited, so it’s important that families consider genetic screening, based on their circumstances.

If you have been diagnosed with genetic haemochromatosis c282y/c282y (known as c282y homozygote), doctors recommend that all your siblings, parents and adult children get tested for the condition.

If you have been diagnosed with genetic haemochromatosis c282y/h63d (known as compound heterozygote), we also recommend that family members should be tested.

Published: 16th May, 2024

Updated: 5th September, 2025

Author: Neil McClements

Share this page
  • Email
  • Facebook
  • Twitter

Latest

  • What are we up to during International Awareness Week?

    What are we up to during International Awareness Week?

    The 1st - 7th June 2026 is Word Haemochromatosis Awareness Week! Find out how we will be raising awareness across the UK!

  • TCS London Marathon 2027 Charity Place

    TCS London Marathon 2027 Charity Place

    Could you be up to the challenge of running The TCS London Marathon in 2027 for Haemochromatosis UK? UPDATE - BOTH PLACES NOW ALLOCATED.

  • Notification of a personal data breach

    Notification of a personal data breach

    We are sorry to inform you that we have experienced a breach of security that has resulted in the unauthorised access to your personal data.

  • Blood Red Shamrock - Now Available in the Shop!

    Blood Red Shamrock - Now Available in the Shop!

    The blood red shamrock pin-badge is now available from the Haemochromatosis UK shop. The quality metal enamel badge can be used to increase awareness of the haemochromatosis cause.

Related

  • Iron Overload Buddies - We are Here for You!

    Iron Overload Buddies - We are Here for You!

    Newly Diagnosed? Our Iron Overload Buddies are here for you!

  • Order a Test Kit Today!

    Order a Test Kit Today!

    A GH test direct from the charity, a result within two weeks of return and a consultation with our Advanced Nurse Practitioner. Available online now.

  • Help lines

    Help lines

    Our help lines are available by phone and email. Worried about genetic haemochromatosis? Don't be. Talk to us for friendly, practical help & understanding.

  • A guide to preparing for venesection

    A guide to preparing for venesection

    Venesection is mainstay treatment for haemochromatosis. Read our advice on how to best prepare yourself before a venesection and what to consider afterwards.

  • Your NHS Rights

    Your NHS Rights

    Everyone deserves great NHS care. But if something goes wrong or isn’t working for you, what can you do?

  • GH & Your Employment Rights

    GH & Your Employment Rights

    This essential guide, produced by the employment law team at Gowling WLG (UK) LLP, explains your employment rights if you have genetic haemochromatosis.

  • Mental Health and Haemochromatosis

    Mental Health and Haemochromatosis

    Leaflets discussing the issues of brain fog, mood swings, depression and anxiety that people diagnosed with genetic haemochromatosis frequently report and where to get help.

  • Kids Zone

    Kids Zone

    Resources for children and young people affected by genetic haemochromatosis. Published March 2021.

  • Can I donate blood?

    Can I donate blood?

    People with genetic haemochromatosis, who have reached maintenance can be accepted as blood donors. Find out more here.

  • Living well with GH

    Living well with GH

    Changes to your diet cannot prevent iron overload. Check out our guide to healthy eating.

Most read

  • Order a Test Kit Today!

    Order a Test Kit Today!

    A GH test direct from the charity, a result within two weeks of return and a consultation with our Advanced Nurse Practitioner. Available online now.

  • What is genetic haemochromatosis?

    What is genetic haemochromatosis?

    Genetic haemochromatosis (GH) is a genetic disorder that increases the risk of the body absorbing an excessive amount of iron from the diet.

  • Breakfast Cereals and their Iron Content

    A rough guide to the Iron content in cereals

  • Treatment & Care

    Treatment & Care

    With treatment, many people live full and active lives with genetic haemochromatosis. Here's what to expect.

  • Clinical Guidelines for Genetic Haemochromatosis

    Clinical Guidelines for Genetic Haemochromatosis

    Published in 2025, this patient-centred guideline sets out a framework for high-quality, evidence-based care in primary and secondary care settings for people with genetic haemochromatosis.

  • HFE (Type 1) Genetic Haemochromatosis

    HFE (Type 1) Genetic Haemochromatosis

    Genetic haemochromatosis is an autosomal recessive condition, meaning that it is inherited. Whether someone inherits the condition, depends upon their parents' genetics.

  • Employers' guide to haemochromatosis

    Employers' guide to haemochromatosis

    People with genetic haemochromatosis want to play an active role in society. These guidelines are intended to help employers understand how they can help people with genetic haemochromatosis in the workplace.

  • Haemochromatosis Carriers

    Carrier is the term used when someone has been shown to have inherited a single copy of the HFE gene mutation from one of the parents. This is sometimes called a heterozygous carrier. Carriers might be at risk of iron loading.

  • H63D carrier (also known as “H63D heterozygous”)

    If you are a “H63d carrier” it means that you have inherited a single copy of the H63d variant from one of your parents.

  • Help lines

    Help lines

    Our help lines are available by phone and email. Worried about genetic haemochromatosis? Don't be. Talk to us for friendly, practical help & understanding.

Tag cloud

In Memory

Sign up for our monthly newsletter

Please enter your first name
Please enter your last name
Please enter your email address Please enter a valid email address (e.g. [email protected])
  • Contact us
  • FAQs
  • Our Policies
  • Privacy Policy
  • Accessibility
  • Sitemap
  • Twitter
  • Facebook
  • YouTube
  • Linkedin

Registered office: The Flaxmill, Flaxmill Lane, Pinchbeck, Spalding PE11 3YP.
Phone: 03030 401 101 / Email: [email protected] / Open: Mon–Fri 9am–3pm

Registered as Charity number 1001307 and SCO41701. Company Limited by Guarantee No. 2541361.
Copyright © 2026 Haemochromatosis UK. All Rights Reserved.

© 2026 Haemochromatosis UK

Manage Cookie Preferences